AssayIndex
Reports by quarter

Reports submitted in 2026-Q2 · page 28

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 99.00 % area, n=1126. Read the 2026-Q2 state-of-the-index report →

1,126 records29 pagesmedian on this page 98.61 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043205GHK-CuSGNSGN-2603-X8452PeptideMeter2026-Q298.934.03—Supplier-supplied0PASS
AX-2026-043164Enclomiphene citrateSSASSA-2603-C7061Kestrel2026-Q298.483.27107.4Buyer-sourced2FAIL
AX-2026-042919BPC-157MKMMKM-2605-X3574PeptideMeter2026-Q298.753.1392.9Buyer-sourced1MARGINAL
AX-2026-042803RetatrutideGGPepsGGPE-2512-D2133Janoshik2026-Q298.513.75—Buyer-sourced0PASS
AX-2026-042735TirzepatideGGPepsGGPE-2604-H1052Janoshik2026-Q299.341.8997.6Buyer-sourced0PASS
AX-2026-042030SS-31 (Elamipretide)HYBHYB-2512-B6579Janoshik2026-Q299.931.4198.8Buyer-sourced0PASS
AX-2026-041917MazdutideSinoPepSNP-2602-U4281Janoshik2026-Q298.023.9890.6Buyer-sourced1MARGINAL
AX-2026-043547CagrilintideSIGSIG-2603-6212Janoshik2026-Q298.284.9697.6Buyer-sourced0PASS
AX-2026-043420BPC-157WXTWXT-2602-W3200Medutest2026-Q298.034.96107.4Buyer-sourced0PASS
AX-2026-043132BPC-157SSASSA-2601-N6863Janoshik2026-Q298.034.34—Buyer-sourced1MARGINAL
AX-2026-042805RetatrutideGGPepsGGPE-2512-D2133Janoshik2026-Q298.493.4192.6Buyer-sourced0PASS
AX-2026-041771RetatrutideASYASY-{CAT}-1505Kestrel2026-Q297.576.9094.3Buyer-sourced0PASS
AX-2026-041286SemaglutideWWBWWB-2603-N3120VendorInvestigate2026-Q298.376.6594.7Buyer-sourced1MARGINAL
AX-2026-041217ThymulinWWBWWB-2602-S2129Janoshik2026-Q299.084.22102.3Buyer-sourced0PASS
AX-2026-043340BPC-157WXTWXT-2603-K2168VendorInvestigate2026-Q297.204.20—Buyer-sourced0FAIL
AX-2026-043244GHK-CuCPCCPC-2601-D1258VendorInvestigate2026-Q298.256.74—Buyer-sourced0PASS
AX-2026-042776SemaxGGPepsGGPE-2512-Y1048PeptideMeter2026-Q299.447.77—Laboratory-retained0PASS
AX-2026-041646SS-31 (Elamipretide)FGPFGP-2601-R8955Janoshik2026-Q298.273.4590.7Buyer-sourced1FAIL
AX-2026-043246GHK-CuCPCCPC-2601-D1258Janoshik2026-Q298.526.89—Buyer-sourced0PASS
AX-2026-042736TirzepatideGGPepsGGPE-2604-H1052Janoshik2026-Q299.501.90—Laboratory-retained0PASS
AX-2026-042541AOD-9604HJHJ-2601-N5554Janoshik2026-Q299.505.3892.8Buyer-sourced1MARGINAL
AX-2026-041947TirzepatideAMBAMB-2602-L4999Medutest2026-Q299.693.80—Buyer-sourced0PASS
AX-2026-041887SemaglutideSinoPepSNP-2511-P4283Janoshik2026-Q298.044.11—Buyer-sourced1MARGINAL
AX-2026-042137PT-141 (Bremelanotide)JEEPJEEP-2601-K8195Janoshik2026-Q298.123.79104.8Buyer-sourced1FAIL
AX-2026-043637CJC-1295 (no DAC)PPGPPG-2512-D7211Kestrel2026-Q299.884.50—Buyer-sourced0PASS
AX-2026-043633CJC-1295 (no DAC)PPGPPG-2512-D7211Janoshik2026-Q299.645.48—Buyer-sourced0PASS
AX-2026-043313TB-500CPCCPC-2605-B1397Medutest2026-Q298.465.14101.8Buyer-sourced0FAIL
AX-2026-0430495-Amino-1MQKPKP-2511-W5347Kestrel2026-Q299.534.30—Buyer-sourced0FAIL
AX-2026-043039RetatrutideKPKP-2604-N4863Janoshik2026-Q298.384.8294.3Buyer-sourced0PASS
AX-2026-042031SS-31 (Elamipretide)HYBHYB-2512-B6579Janoshik2026-Q299.361.56101.6Buyer-sourced0PASS
AX-2026-041293SemaglutideWWBWWB-2603-N3120VendorInvestigate2026-Q299.085.9097.7Buyer-sourced1MARGINAL
AX-2026-043575PEG-MGFSIGSIG-2602-6794VendorInvestigate2026-Q297.415.63—Buyer-sourced0PASS
AX-2026-043136BPC-157SSASSA-2601-N6863Janoshik2026-Q298.524.0292.4Buyer-sourced1MARGINAL
AX-2026-042594TirzepatideHJHJ-2511-B6617Janoshik2026-Q299.105.4891.1Buyer-sourced0PASS
AX-2026-042039EpitalonHYBHYB-2603-U7133Medutest2026-Q299.936.17103.9Buyer-sourced0FAIL
AX-2026-0430465-Amino-1MQKPKP-2511-W5347Medutest2026-Q299.684.10—Buyer-sourced0FAIL
AX-2026-042918RetatrutideGGPepsGGPE-2604-X3153Janoshik2026-Q298.005.79107.0Buyer-sourced0PASS
AX-2026-042886BPC-157GGPepsGGPE-2605-B2560Janoshik2026-Q298.713.87—Buyer-sourced0PASS
AX-2026-042483N-Acetyl Semax AmideHomopeptideHOMO-2603-C5267Janoshik2026-Q299.108.34—Buyer-sourced0PASS
AX-2026-042481N-Acetyl Semax AmideHomopeptideHOMO-2603-C5267PeptideMeter2026-Q299.098.7592.9Buyer-sourced0PASS